Lazard Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $307K | Sell |
|
|||||
|
2025
Q1 | $396K | Sell |
|
|||||
|
2024
Q4 | $689K | Sell |
|
|||||
|
2024
Q3 | $1.72M | Sell |
|
|||||
|
2024
Q2 | $1.54M | Sell |
|
|||||
|
2024
Q1 | $2.02M | Sell |
|
|||||
|
2023
Q4 | $2.71M | Sell |
|
|||||
|
2023
Q3 | $3.09M | Sell |
|
|||||
|
2023
Q2 | $3.93M | Sell |
|
|||||
|
2023
Q1 | $3.89M | Buy |
|
|||||
|
2022
Q4 | $3.42M | Sell |
|
|||||
|
2022
Q3 | $5.61M | Buy |
|
|||||
|
2022
Q2 | $7.09M | Buy |
|
|||||
|
2022
Q1 | $9.73M | Buy |
|
|||||
|
2021
Q4 | $12.7M | Buy |
|
|||||
|
2021
Q3 | $3.9M | Buy |
|
|||||
|
2021
Q2 | $4.12M | Buy |
|
|||||
|
2021
Q1 | $1.17M | Buy |
|
|||||
|
2020
Q4 | $816K | Buy |
|